• STJ70621 (0. 5µg/ml) staining of Human Thymus, Human Lymph node and Human Tonsil lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.

Anti-Swiprosin 1/EFHD2 antibody (C-Term) (STJ70621)

SKU:
STJ70621-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB
Reactivity: Human/Mouse/Rat/Dog/Cow
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-Swiprosin 1/EFHD2 (C-Term) is suitable for use in ELISA and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-0.5-1.5µg/ml
ELISA-antibody detection limit dilution 1:128000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: EFHD2
Gene ID: 79180
Uniprot ID: EFHD2_HUMAN
Immunogen Region: C-Term
Accession Number: NP_077305.2
Specificity: This antibody does not cross-react with Mouse Swiprosin 2. Data kindly provided by Sebastian Duetting and Dirk Mielenz.
Immunogen Sequence: CAAFKELQSTFK
Function May regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. Plays a role as negative regulator of the canonical NF-kappa-B-activating branch. Controls spontaneous apoptosis through the regulation of BCL2L1 abundance.
Protein Name Ef-Hand Domain-Containing Protein D2
Swiprosin-1
Database Links Reactome: R-HSA-9013405
Cellular Localisation Membrane Raft
In A Mouse Immature B-Cell Line Wehi-231
Alternative Antibody Names Anti-Ef-Hand Domain-Containing Protein D2 antibody
Anti-Swiprosin-1 antibody
Anti-EFHD2 antibody
Anti-SWS1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance